Skip to content
Riskpilot
← Back to search
Sign in
Get full access
ATI Pharmaqua AB
AB
Active
Org 5592565708
Junkervägen 11, 187 36
Täby
All other professional, scientific and technical activities n.e.c.
· NACE 7499
Est. 2020
0 employees
Watchlist
Share
Sweden
/
Companies
/
All other professional, scientific and technical activities n.e.c.
/
ATI Pharmaqua AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
1M
1M
2M
2M
2M
2021
2M
2022
2M
2023
2M
2024
2M
2025
EBITDA
SEK millions
0M
1M
1M
2M
2M
2M
2021
1M
2022
1M
2023
0M
2024
1M
2025
Income statement
SEK thousands
Item
2021
2022
2023
2024
2025
Revenue
1 817
2 411
2 097
1 690
2 239
Staff expenses
—
−1 119
−1 268
−1 035
−1 241
EBITDA
1 614
1 194
720
483
849
Depreciation & amort.
−0
—
—
—
—
EBIT
1 614
1 194
720
483
849
Net financials
—
7
—
124
51
Profit before tax
1 614
1 201
720
607
900
Tax
−333
−247
−148
−125
−185
Net profit
1 281
954
571
482
714
Balance sheet
SEK thousands
Item
2021
2022
2023
2024
2025
Total assets
3 248
3 850
3 837
3 568
4 392
Equity
2 135
2 901
3 083
3 104
3 450
Long-term debt
0
—
—
—
—
Short-term debt
1 113
949
755
465
941
Total debt
1 113
949
755
465
941
Financial ratios
5-year trend
EBITDA margin
37.9%
This company
15.8%
Market median
+140% vs market
2021
2025
Equity ratio
78.6%
This company
38.2%
Market median
+106% vs market
2021
2025
Return on equity
20.7%
This company
18.4%
Market median
+13% vs market
2021
2025
Net profit margin
31.9%
This company
8.1%
Market median
+294% vs market
2021
2025
Asset turnover
0.51×
This company
1.12×
Market median
-54% vs market
2021
2025
Debt / equity
0.27×
This company
0.62×
Market median
+56% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
More on ATI Pharmaqua AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
